NOV 16, 2020 7:00 AM PST

Measles Is Back and COVID Isn't Helping

WRITTEN BY: Tara Fernandez

Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person becomes infected with the virus, of which children are the most common victims. Overall, vaccination has slashed measles-related deaths by 80 percent between 2000 and 2017. The measles vaccine, developed in the early 1960s is safe and very effective. So why then has measles come back with a vengeance, causing deaths to skyrocket worldwide?

The problem seems to lie in gaps in herd immunity. To prevent disease outbreaks, experts estimate around 95 percent of people within a community need to be immunized. According to Natasha Crowcroft, from WHO’s Measles and Rubella Control in Geneva, global vaccinations have tapered off at around 84 to 85 percent, which over time leads to the accumulation of susceptible children and the onset of outbreaks.

A new study that tracked outbreaks across nine countries highlights the importance of vaccination coverage in limiting measles-related deaths. Different obstacles stand in the way of this coverage amongst different communities. In Samoa, for instance, fewer children were taken for their measles shots as fearful parents reacted to a medical error in 2018 that led to the death of two infants. In Ukraine, health care workers were not confident about the efficacy of vaccines and consequently didn’t push for them to be administered.

COVID-19 has further complicated matters: disruptions in immunization programs during lockdowns and the economic slump increasing rates of malnutrition being among factors contributing to this. Vitamin deficiencies in children can lead to more severe and life-threatening forms of the disease. “These issues tend to cluster in the same communities, exacerbating the total effect and increasing inequity,” said Crowcroft.

Winning the war against measles would mean regaining control of global immunization programs, say experts. Emerging technologies such as vaccine patches that don’t require cold storage and injections could also be transformative in the future. For now, it seems measles continues to have the upper hand with case numbers on the steady incline.

 


Sources: Science News, CDC.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 18, 2021
Drug Discovery & Development
COVID-19 Antibiotic No More Effective than Placebo
JUL 18, 2021
COVID-19 Antibiotic No More Effective than Placebo
Azithromycin, a broad-spectrum antibiotic commonly used to prevent symptoms of COVID-19 in non-hospitalized patients, do ...
AUG 03, 2021
Immunology
Some Neutralizing Antibodies Make COVID Worse
AUG 03, 2021
Some Neutralizing Antibodies Make COVID Worse
Antibodies are specialized proteins produced as part of the body's immune response. Neutralizing antibodies bind to ...
AUG 26, 2021
Immunology
Sugar-Coating Organs Stops Them From Getting Rejected
AUG 26, 2021
Sugar-Coating Organs Stops Them From Getting Rejected
Once organ failure patients receive the gift of a transplant, they face a life-long threat of immune rejection. Their im ...
AUG 25, 2021
Cell & Molecular Biology
Sino Biological's Listing on the Shenzhen Stock Exchange
AUG 25, 2021
Sino Biological's Listing on the Shenzhen Stock Exchange
China, August 16, 2021 - Sino Biological, Inc. (“Sino Biological” or the “Company”), a biot ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
OCT 19, 2021
Immunology
Mild COVID Produces Better Than Expected Antibody Responses
OCT 19, 2021
Mild COVID Produces Better Than Expected Antibody Responses
Over millions of years, the immune system has evolved to shield us against disease-causing pathogens that we encounter e ...
Loading Comments...